SE9700617D0 - New composition - Google Patents

New composition

Info

Publication number
SE9700617D0
SE9700617D0 SE9700617A SE9700617A SE9700617D0 SE 9700617 D0 SE9700617 D0 SE 9700617D0 SE 9700617 A SE9700617 A SE 9700617A SE 9700617 A SE9700617 A SE 9700617A SE 9700617 D0 SE9700617 D0 SE 9700617D0
Authority
SE
Sweden
Prior art keywords
composition
pharmaceutical composition
new composition
lozenge
urine
Prior art date
Application number
SE9700617A
Other languages
English (en)
Inventor
Kjell Alving
Eddie Weitzberg
Jan M Lundberg
Peter Wiklund
Jon Lundberg
Original Assignee
Kjell Alving
Eddie Weitzberg
Jan M Lundberg
Peter Wiklund
Jon Lundberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kjell Alving, Eddie Weitzberg, Jan M Lundberg, Peter Wiklund, Jon Lundberg filed Critical Kjell Alving
Priority to SE9700617A priority Critical patent/SE9700617D0/sv
Publication of SE9700617D0 publication Critical patent/SE9700617D0/sv
Priority to AU61283/98A priority patent/AU6128398A/en
Priority to PCT/SE1998/000301 priority patent/WO1998047495A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/02Ammonia; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9700617A 1997-02-21 1997-02-21 New composition SE9700617D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9700617A SE9700617D0 (sv) 1997-02-21 1997-02-21 New composition
AU61283/98A AU6128398A (en) 1997-02-21 1998-02-20 New composition
PCT/SE1998/000301 WO1998047495A1 (en) 1997-02-21 1998-02-20 New composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700617A SE9700617D0 (sv) 1997-02-21 1997-02-21 New composition

Publications (1)

Publication Number Publication Date
SE9700617D0 true SE9700617D0 (sv) 1997-02-21

Family

ID=20405878

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700617A SE9700617D0 (sv) 1997-02-21 1997-02-21 New composition

Country Status (3)

Country Link
AU (1) AU6128398A (sv)
SE (1) SE9700617D0 (sv)
WO (1) WO1998047495A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
CN1455674B (zh) * 2000-07-11 2019-03-29 艾库里斯有限及两合公司 绵羊副痘病毒菌株用于制备抗病毒药物和抗癌药物的用途
GB0021317D0 (en) 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047878A1 (en) * 1969-06-13 1971-03-19 Chanteaud Laboratoires Treatment of pheasants using arginine, - ascorbic acid and mineral salts
FR2459047A1 (fr) * 1979-06-19 1981-01-09 Begouen Jean Paul Medicament veterinaire a base de nitrates destine au traitement de la diarrhee des jeunes veaux
CH629100A5 (de) * 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
NL8401782A (nl) * 1984-06-04 1986-01-02 Jan Willem Bins Therapeutisch preparaat met ammoniumnitraat als werkzame stof.
DD281543A5 (de) * 1988-06-17 1990-08-15 Univ Leipzig Herstellungsverfahren fuer ein mittel zur verbesserung der muskulaeren aeroben leistungsfaehigkeit, insbesondere bei trainings- und wettkampfbelastungen
JP3875262B2 (ja) * 1994-02-21 2007-01-31 アバディーン ユニヴァーシティ 殺菌剤としての酸性化したニトリット

Also Published As

Publication number Publication date
AU6128398A (en) 1998-11-13
WO1998047495A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
DE60125217D1 (de) Transdermale pharmazeutische zusammensetzung zur wirkstoffverabreichung
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
CO4970819A1 (es) Tratamiento de disfuncion sexual femenina en una hembra humana
IL119627A0 (en) Controlled-release pharmaceutical preparations
BR0010082A (pt) Método para melhorar a eficácia de um agente antitumoral
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
ES2125696T3 (es) Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.
CA2231176A1 (en) Long active composition for rectal administration
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
FR2784897B1 (fr) Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
SE9700617D0 (sv) New composition
KR900005974A (ko) 남성의 성기능 장애 치료제
BR0008385A (pt) Laxantes efervescentes
HUP0302984A2 (hu) Buprenorphin felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
AU2001295839A1 (en) Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa
ES2189639A1 (es) Composicion acuosa que contiene acido acetilsalicilico
WO2001028566B1 (en) Use of acetyl salicilyc acid for the treatment of benign prostate hyperplasia
RU2000103385A (ru) Способ лечения острого панкреотита
UA30359A (uk) Спосіб лікування гнійних ран